“CRISPR-CAS9 GENE EDITING THERAPEUTICS: FROM FIRST APPROVAL TO EXPANDING CLINICAL PIPELINE”, GCM, vol. 1, no. 9, pp. 29–36, Sep. 2026, Accessed: Oct. 31, 2026. [Online]. Available: https://www.econferencia.com/index.php/5/article/view/1409